---
figid: PMC11201226__biomedicines-12-01140-g002
pmcid: PMC11201226
image_filename: PMC11201226__biomedicines-12-01140-g002.jpg
figure_link: /pmc/articles/PMC11201226/figure/F2/
number: Figure 2
figure_title: Proteomic differential analysis in irAEs three days after treatment.
caption: Proteomic differential analysis in irAEs three days after treatment. (a)
  Heatmap of plasma differential proteins in patients with irAEs three days after
  treatment. (b) Volcano plot of plasma differential proteins in patients with irAEs
  three days after treatment. (c) KEGG pathway enrichment analysis of plasma differential
  proteins in patients with irAEs three days after treatment
article_title: Activation of CD14+ Monocytes via the IFN-γ Signaling Pathway Is Associated
  with Immune-Related Adverse Events in Hepatocellular Carcinoma Patients Receiving
  PD-1 Inhibition Combination Therapy
citation: Yaoru Song, et al. Biomedicines. 2024 Jun;12(6).
year: '2024'
pub_date: 2024-6-
epub_date: 2024-5-21
doi: 10.3390/biomedicines12061140
journal_title: Biomedicines
journa_nlm_ta: Biomedicines
publisher_name: MDPI
keywords:
- hepatocellular carcinoma
- immune-related adverse events
- checkpoint inhibitor
- monocytes
- IFN-γ signaling
---
